Qube Research & Technologies Ltd

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1729829 LONDON, X0

Position in ARQT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$17,059,018

-$2,148,473 QoQ

Shares Held

724,067

+9.5% QoQ

Ownership

0.579%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,033,804,065 across 186 Biotechnology names. ARQT ranks #34 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$17,059,018	724,067	+9.5%	Shares	Sole	2026-05-15
2025-12-31	$19,207,491	661,415	-18.8%	Shares	Sole	2026-02-17
2025-09-30	$15,354,587	814,567	+41.1%	Shares	Sole	2025-11-14
2025-06-30	$8,096,451	577,493	+200.4%	Shares	Sole	2025-08-14
2025-03-31	$3,006,305	192,219	+840.8%	Shares	Sole	2025-05-15
2024-09-30	$190,017	20,432	-97.2%	Shares	Sole	2024-11-14
2023-12-31	$2,344,637	725,894	+5225.3%	Shares	Sole	2024-02-13
2023-06-30	$129,903	13,631	-33.6%	Shares	Sole	2023-08-14
2023-03-31	$225,852	20,532	-64.8%	Shares	Sole	2023-05-15
2022-12-31	$862,603	58,284	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.